Presbyopia IOL Panel Probes Concerns About Trial Sponsor Burdens
This article was originally published in The Gray Sheet
Executive Summary
Clinical trials of clear lens extraction (CLE) to treat presbyopia should strive for uncorrected distance visual acuity of 20/25 or 20/30 in 90%-95% of patients, members of FDA's Ophthalmic Devices Panel suggested at a March 5 meeting in Gaithersburg, Md